Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

YELLOX 0,9 mg/ml COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/YELLOX 0,9 mg/ml COLIRIO EN SOLUCION

Approved

STANDARD

YELLOX 0,9 mg/ml COLIRIO EN SOLUCION

Bausch Health Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 2, 2021
Approval ID: 9c3cfeef2ac3ce22
Company: Bausch Health Ireland Limited
Type: Standard

Approval Details

Approval Id: 9c3cfeef2ac3ce22
Drug Cima Aemps Name: YELLOX 0,9 mg/ml COLIRIO EN SOLUCION
Register Number: 11692001IP4
Holder Company Name: Bausch Health Ireland Limited
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/bausch-health-ireland-limited
Authorization Date: 2021-07-02
Dosage Form: COLIRIO EN SOLUCIÓN
Dose: 0,9 mg
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Bausch Health Ireland Limited
Company Detail Path: /organization/bausch-health-ireland-limited

Company Information

Pharmaceutical Company Name: BAUSCH HEALTH IRELAND LIMITED
Country Name: Ireland
City Name: dublin,country_ie
Address: Citywest Business Campus

Active Ingredients

BROMFENACO SODICO SESQUIHIDRATO

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 2, 2021

Approval ID

9c3cfeef2ac3ce22

Type

Standard

Back to CIMA-AEMPS Approvals